Dr. Teo Soleymani, MD

Dr. Soleymani practices at UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health.

Dr. Soleymani's NPI, 1447679865, was assigned on April 14, 2014. Dr. Soleymani graduated from UC Irvine School of Medicine in 2014. Dr. Soleymani's California license number on file is A144007.

Dr. Soleymani's primary practice is UCLA Santa Monica Medical Center, at 1250 16th Street, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 319-4000.

Dr. Soleymani's primary practice is UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health. The medical group on file is Golden State Wound Care. Dmand AI also links Dr. Soleymani to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Soleymani practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Soleymani's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Soleymani is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Soleymani's licenses on file in 3 states: California, Pennsylvania and New York.

Dmand AI lists benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, itchy rashes, rash, scalp rash, skin cyst and skin discoloration among the conditions Dr. Soleymani treats.

CMS data shows 5,195 Medicare services from Dr. Soleymani across 35 procedure codes in 2024, for 433 Medicare patients. Medicare paid $711,227 for them. Every service was in an office.

CMS counts 433 Medicare patients who saw Dr. Soleymani in 2024. The largest group is 65 to 74, with 207 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 29% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Soleymani's median patient age at 64, with 49% women.

In 2024, Dr. Soleymani wrote 719 Medicare Part D claims for 271 patients. 99% of them were for generic drugs. CMS names the drug for 604 of them, across 16 drugs with 11 or more claims each, at $12,387 in total drug cost. In 2023, CMS named 204 claims across 7 drugs.

Dr. Soleymani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 376 procedures of melanoma (skin cancer) excision by Dr. Soleymani, more than 99% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 36 papers to Dr. Soleymani, published from 2011 to 2024. 2015 was the busiest year, with 3. The most frequent topics are Skin Neoplasms, Mohs Surgery and Melanoma. Dr. Soleymani has published most often in Dermatol Surg. Dr. Soleymani's most frequent co-authors are Sumaira Zareen Aasi, MD, Michael E. Abrouk, MD and Nada M. Elbuluk, MD.

CMS Open Payments shows 70 general payments to Dr. Soleymani from 16 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 76% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $16,376.

Dmand AI lists 1 award for Dr. Soleymani.

Dr. Soleymani graduated from UC Irvine School of Medicine in 2014.

Dr. Soleymani is in network with 15 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.